Thus, while immune cell STAT1 activity is strongly associated with HNSCC survival and can be considerably variable among patients [11], our data supports the hypothesis that STAT1 activation by HNSCC cells could simultaneously potentiate immunosuppressive and tumorigenic effects during HNSCC. Here, STAT1 is linked to head and neck squamous cell carcinoma.